Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.9000 (-3.66%) ($7.4600 - $8.1100) on Thu. Aug. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.46% (three month average) | RSI | 70 | Latest Price | $7.9000(-3.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BND(43%) EDOC(20%) TLT(14%) GLD(12%) CEMB(11%) | Factors Impacting CAPR price | CAPR will decline at least -4.23% in a week (0% probabilities). XLB(-24%) XLI(-21%) PAVE(-21%) XOP(-20%) VYM(-19%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.23% (StdDev 8.46%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $7.96(-0.75%) | 10 Day Moving Average | $8.35(-5.39%) | 20 Day Moving Average | $6.89(14.66%) | To recent high | -19.5% | To recent low | 57.7% | Market Cap | $156m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |